|
Name |
Type |
Discontinued? |
|
| 1 |
RESULT_ID |
VARCHAR |
No |
|
|
|
| The unique identifier for the result record. |
|
|
| 2 |
NEOADJUVANT_THRPY_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Neoadjuvant Therapy. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Yes |
| No |
| Indeterminate |
|
|
| 3 |
NEOADJ_THRPY_TYPE |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Neoadjuvant Therapy Type. |
|
|
| 4 |
TUMOR_SITE_SPECIFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify tumor site. |
|
|
| 5 |
SPEC_RECEIVED_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specimen Received. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Fresh |
| In formalin |
| Other |
|
|
| 6 |
SPEC_RECV_SPECIFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify Other Specimens Received. |
|
|
| 7 |
CAP_COMMENTS |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: General comments. |
|
|
| 8 |
SPEC_INTEGRITY_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specimen Integrity. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Intact |
| Fragmented |
| Single intact specimen (margins can be evaluated) |
| Multiple designated specimens (e.g., main excision and identified margins) |
| Fragmented (margins cannot be evaluated with certainty) |
| Morcellated hysterectomy specimen |
| Intact hysterectomy specimen |
| Disrupted |
| Indeterminate |
| Other |
| Not specified |
|
|
| 9 |
SIZE_LARGST_POS_LYM |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Size (greatest dimension, in cm) of the Largest Positive Lymph Node. |
|
|
| 10 |
SPEC_PROC_SPECIFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify the Specimen Procedure. |
|
|
| 11 |
SPEC_SIZE_GREATEST |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Specimen Greatest Size. |
|
|
| 12 |
SPEC_SIZE_ADDL |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Specimen size additional dimension (length). |
|
|
| 13 |
SPEC_SIZE_ADDL2 |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Specimen size additional dimension (width). |
|
|
| 14 |
SPEC_ADDL_GREATEST |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Additional specimen greatest size. |
|
|
| 15 |
SPEC_ADDL_LENGTH |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Additional specimen size additional dimension (length). |
|
|
| 16 |
SPEC_ADDL_WIDTH |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Additional specimen size additional dimension (width). |
|
|
| 17 |
MICRO_TMR_EXT_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify Microscopic Tumor Extension. |
|
|
| 18 |
MRG_CANNOT_ASSES_YN |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Margins Cannot Be Assessed. |
| May contain organization-specific values: No |
| Category Entries: |
| No |
| Yes |
|
|
| 19 |
MARGIN_UNITS_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Margin Units. |
| May contain organization-specific values: Yes |
| Category Entries: |
| mm |
| cm |
|
|
| 20 |
TREATMENT_EFFECT_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Treatment Effect. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Not identified |
| No prior treatment |
| Not applicable |
| Present |
| No definite response identified (grade 3, poor/no response; extensive residual tumor) |
| No definite response identified (grade 3, poor or no response) |
| Greater than 10% residual viable tumor |
| Less than 10% residual viable tumor |
| Greater than 50% residual viable tumor |
| Less than 50% residual viable tumor |
| No definite or minimal response identified (poor or no response) |
| Marked response (minimal residual cancer) |
| No known presurgical therapy |
| No definite response to presurgical therapy |
| Probable or definite response to presurgical therapy |
| Cannot be determined |
| Indeterminate |
| Not known |
|
|
| 21 |
TREAT_EFF_SPECIFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify treatment effect. |
|
|
| 22 |
TUMOR_DESC_SPECIFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify tumor description. |
|
|
| 23 |
PERINEURAL_INVASN_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Perineural Invasion. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Cannot be assessed |
| Not identified |
| Absent |
| Present |
| Indeterminate |
| Portal vein invasion present |
| Hepatic vein invasion present |
| Present within tumor nodules |
| Present in vessels of parenchyma outside of tumor nodules |
| Cannot be determined |
|
|
| 24 |
LYM_ND_EXNDL_EXT_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Lymph Nodes, Extranodal Extension. |
| The category values for this column were already listed for column: PERINEURAL_INVASN_C_NAME |
|
|
| 25 |
SPECIMEN_OTHER_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify other specimen. |
|
|
| 26 |
REG_LN_NUM_EXM |
INTEGER |
No |
|
|
|
| CAP synoptic form item: Regional Lymph Nodes Number Examined. |
|
|
| 27 |
REG_LN_NUM_INV |
INTEGER |
No |
|
|
|
| CAP synoptic form item: Regional Lymph Nodes Number Involved. |
|
|
| 28 |
SRC_PATH_METAS_SPEC |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Source of Pathologic Metastatic Specimen Specify. |
|
|
| 29 |
DISTNT_METASTASIS_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Distant Metastasis. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Not applicable |
| cM0 (i+): No clinical or radiographic evidence of distant metastasis |
| pM0: No distant metastasis |
| pM1: Distant metastasis |
| pM1a: Intraperitoneal metastasis beyond the right lower quadrant, including pseudomyx |
| pM1b: Nonperitoneal metastasis |
| pM1: Distant detectable metastasis as determined by classic clinical |
| pM1 (IVB): Distant metastasis |
| pM1a: Separate tumor nodule(s) in contralateral lung; tumor with pleural nodules or |
| pM1b: Distant metastases outside the lung / pleura |
| pM1: Distant metastasis (documented in this specimen) |
| pM1a: Metastasis in skin, subcutaneous tissues, or distant lymph nodes |
| pM1b: Metastasis to lung |
| pM1c: Metastasis to all other visceral sites or distant metastasis at any site |
| pM1a: Nonregional lymph node(s) |
| pM1b: Bone(s) |
| pM1c: Other site(s) with or without bone disease |
| pM1: Metastasis to sites other than CNS |
| pM1a: Single lesion |
| pM1b: Multiple lesions |
| pM1c: CNS metastasis |
| pM1d: Discrete mass(es) without leptomeningeal and / or CSF involvement |
| pM1e: Leptomeningeal and / or CSF involvement |
| pM1a: Non-regional lymph nodes or pulmonary metastasis |
| pM1b: Distant metastasis other than to nonregional lymph nodes and lungs |
| pM1a (III): Tumor extends to the lungs with or without genital tract involvement |
| pM1b (IV): Tumor involves other metastatic sites |
| pM1a: Largest diameter of the largest metastasis 3 cm or less |
| pM1b: Largest diameter of the largest metastasis 3.1-8.0 cm |
| pM1c: Largest diameter of the largest metastasis 8 cm or more |
| pM1a: Lung |
| pM1b: Metastasis involving distant sites other than lung (including skip metastases) |
| Distant Metastasis present (includes metastasis to lymph nodes) |
|
|
| 30 |
DSTNT_METASTATIS_ST |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Distant Metastatis Sites. |
|
|
| 31 |
ADDL_PATH_FIND_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify additional pathologic findings. |
|
|
| 32 |
CLINICAL_HIST_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify clinical history. |
|
|
| 33 |
HISTOLOGIC_GRADE_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Histologic Grade. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Not applicable |
| GX: Cannot be assessed |
| G1: Well differentiated |
| G2: Moderately differentiated |
| G3: Poorly differentiated |
| G4: Undifferentiated |
| G4: Undifferentiated / anaplastic |
| WHO grade not assigned |
| Low-grade (well-differentiated to moderately differentiated) |
| High-grade (poorly differentiated to undifferentiated) |
| FIGO Grade 1 |
| FIGO Grade 2 |
| FIGO Grade 3 |
| Favorable (purely epithelial, fetal subtype, mitotically inactive with <=2 mitoses in |
| Less favorable (all subtypes other than those designated "Favorable" or "Unfavorable" |
| Unfavorable (small cell undifferentiated or rhabdoid as the predominant or sole histo |
| Gleason Pattern |
| Ungraded sarcoma |
| pGX: Grade cannot be assessed |
| pG1: Spindle cell melanoma |
| pG2: Mixed cell melanoma |
| pG3: Epithelioid cell melanoma |
| WHO Grade I |
| WHO Grade II |
| WHO Grade III |
| WHO Grade IV |
| pG1: Well differentiated |
| pG2: Moderately differentiated |
| pG3: Poorly differentiated |
| pG4: Undifferentiated |
| FNCLCC Grade 1 |
| FNCLCC Grade 2 |
| FNCLCC Grade 3 |
| Grade 1 |
| Grade 2 |
| Grade 3 |
| Cannot be determined |
| Other |
|
|
| 34 |
HISTOLGC_GRADE_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify histologic grade. |
|
|
| 35 |
MRG_INV_CARCINOMA_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Margin Invasive Carcinoma. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Cannot be assessed |
| Benign glands at surgical margin |
| No tumor at margins |
| Tumor present at surgical margin of optic nerve |
| Extrascleral extension (for enucleation specimens) |
| No melanoma at margins |
| Margins uninvolved by tumor |
| Margins involved by tumor |
| Margins negative for tumor |
| Margin involvement by tumor not identified |
| Margins uninvolved by invasive carcinoma |
| Margins involved by invasive carcinoma |
| Margins uninvolved by carcinoma |
| Margins involved by carcinoma |
| Margins uninvolved by sarcoma |
| Margins involved by sarcoma |
| Margins positive for sarcoma |
| Sarcoma involvement of margins not identified |
| Margins negative for sarcoma |
| Margins uninvolved by DCIS (DCIS present) |
| Margins positive for DCIS |
| Margins negative for mesothelioma |
| Margins involved by mesothelioma |
| Margins uninvolved by malignant tumor |
| Margins involved by malignant tumor |
| Margins uninvolved by carcinoma in situ |
| Margins involved by carcinoma in situ |
| Indeterminate |
| Cannot be determined |
| Other Margins Involved |
| Not applicable |
|
|
| 36 |
MARGIN_UNITS_2_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Margin Units (second measurement). |
| The category values for this column were already listed for column: MARGIN_UNITS_C_NAME |
|
|
| 37 |
MACRO_EXTENT_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify Macroscopic Extent. |
|
|
| 38 |
NECK_DISSECTN_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify Neck (Lymph Node) Dissection. |
|
|
| 39 |
MUCOEPIDRMD_CARC_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Mucoepidermoid carcinoma. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Low grade |
| Intermediate grade |
| High grade |
|
|
| 40 |
PATHOLOGIC_STAGE_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Pathologic Staging. |
| May contain organization-specific values: Yes |
| Category Entries: |
| For All Carcinomas Excluding Mucosal Malignant Melanoma |
| For Mucosal Malignant Melanoma |
|
|
| 41 |
KERAT_DYSPLS_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Keratinizing dysplasia. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Mild |
| Moderate |
| Severe (carcinoma in situ) |
|
|
| 42 |
NON_KERAT_DYSPLS_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Non-keratinizing dysplasia. |
| The category values for this column were already listed for column: KERAT_DYSPLS_C_NAME |
|
|
| 43 |
MINOR_SALV_GLD_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify Carcinomas of Minor Salivary Glands. |
|
|
| 44 |
NON_SALV_ADENOC_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Non-Salivary Gland Adenocarcinoma, not otherwise specified (NOS). |
| The category values for this column were already listed for column: MUCOEPIDRMD_CARC_C_NAME |
|
|
| 45 |
NON_SALIV_GLD_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Non-Salivary Gland - Specify Adenocarcinoma. |
|
|
| 46 |
NEUROEND_CARC_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify Neuroendocrine Carcinoma. |
|
|
| 47 |
MARGIN_IN_SITU_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Margin In Situ. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Margins uninvolved by carcinoma in situ (includes moderate and severe dysplasia) |
| Margins uninvolved by carcinoma in situ |
| Margins involved by carcinoma in situ (includes moderate and severe dysplasia) |
| Margins involved by carcinoma in situ |
| Not applicable |
|
|
| 48 |
HUMAN_PAPILLOMAVI_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Human Papillomavirus Associated Carcinoma. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Present |
| Negative |
|
|
| 49 |
EPSTEIN_BAR_VIRU_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Epstein-Barr virus. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Present |
| Negative |
|
|
| 50 |
PATH_INFLAM_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Additional Pathological Findings - Specify Inflammation. |
|
|
| 51 |
TMR_FOC_MUL_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Tumor Focality - Specify Multifocal. |
|
|
| 52 |
HIST_TYPE_ADE_NOS_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Histologic Type Adenocarcinomas, Not Otherwise Specified. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Low grade |
| Intermediate grade |
| High grade |
|
|
| 53 |
MARGIN_INV_SPECIFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Margins Invasive Specify Margins Per Orientation. |
|
|
| 54 |
MARGIN_IN_SITU_SPFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Margins In Situ Specify Margins Per Orientation. |
|
|
| 55 |
MARG_INV_DIST_CLOSE |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Margins Invasive Distance of Invasive Carcinoma from Closest Margin. |
|
|
| 56 |
PT_FOR_MUC_MAL_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Primary Tumor for Mucosal Malignant Melanoma. |
| May contain organization-specific values: Yes |
| Category Entries: |
| pT3: Mucosal disease |
| pT4a: Moderately advanced disease. Tumor involving deep soft tissue, cartilage, bone, |
| pT4b: Very advanced disease. Tumor involving brain, dura, skull base, lower cranial n |
|
|
| 57 |
ANCLR_STD_SPEC |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify details for ancillary studies. |
|
|
| 58 |
PATH_STAGE_PT_PN_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Pathologic staging pT and pN. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Oropharynx |
| Nasopharynx |
| Hypopharynx |
|
|
| 59 |
HIS_TYP_NONKERATE_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Histologic Type - Carcinomas of the Nasopharynx - Nonkeratinizing carcinoma. |
| May contain organization-specific values: Yes |
| Category Entries: |
| Differentiated carcinoma (formerly WHO-2; transitional carcinoma) |
| Undifferentiated carcinoma (formerly WHO-3; lymphoepithelioma) |
|
|
| 60 |
MARGIN_SITU_CLOSE |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Margins in Situ Distance of Carcinoma in Situ from Closest. |
|
|
| 61 |
TUMOR_SIZE_GREAT |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Tumor Greatest Size. |
|
|
| 62 |
TUMOR_SIZE_ADDL |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Tumor Size (length). |
|
|
| 63 |
TUMOR_SIZE_ADDL2 |
NUMERIC |
No |
|
|
|
| CAP synoptic form item: Tumor Size (width). |
|
|
| 64 |
TUMOR_SIZE_SPECIFY |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify Tumor Size. |
|
|
| 65 |
SPEC_PROC_RESECT_SP |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Specify Specimen Procedure Resection. |
|
|
| 66 |
PT_OROPHARYNX_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Primary Tumor (pT): Oropharynx. |
| May contain organization-specific values: Yes |
| Category Entries: |
| pTX: Cannot be assessed |
| pT0: No evidence of primary tumor |
| pTis: Carcinoma in situ |
| pT1: Tumor 2 cm or less in greatest dimension |
| pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension |
| pT3: Tumor more than 4 cm in greatest dimension or extension to lingual surface of ep |
| pT4a: Moderately advanced local disease. Tumor invades larynx, deep / extrinsic muscl |
| pT4b: Very advanced local disease. Tumor invades lateral pterygoid muscle, pterygoid |
|
|
| 67 |
PT_NASOPHARYNX_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Primary Tumor (pT): Nasopharynx. |
| May contain organization-specific values: Yes |
| Category Entries: |
| pTX: Cannot be assessed |
| pT0: No evidence of primary tumor |
| pTis: Carcinoma in situ |
| pT1: Tumor confined to nasopharynx, or tumor extends to oropharynx and / or nasal cav |
| pT2: Tumor with parapharyngeal extension# |
| pT3: Tumor invades bony structures of skull base and / or paranasal sinuses |
| pT4: Tumor with intracranial extension and / or involvement of cranial nerves |
|
|
| 68 |
PT_HYPOPHARYNX_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Primary Tumor (pT): Hypopharynx. |
| May contain organization-specific values: Yes |
| Category Entries: |
| pTX: Cannot be assessed |
| pT0: No evidence of primary tumor |
| pTis: Carcinoma in situ |
| pT1: Tmr limited to one subsite of hypopharynx and / or 2 cm or less in dimention |
| pT2: Tmr invades more than one subsite of hypopharynx or adj. site, or >2cm but <4cm |
| pT3: Tmr measures more than 4 cm in greatest dimension or with fixation of hemilarynx |
| pT4a: Moderately advanced local disease. Tumor invades thyroid / cricoid cartilage |
| pT4b: Very advanced local disease. Tmr invades prevertebral fascia, encases carotid |
|
|
| 69 |
PN_OROPHARYNX_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Regional Lymph Nodes (pN): Oropharynx. |
| May contain organization-specific values: Yes |
| Category Entries: |
| pNX: Cannot be assessed |
| pN0: No regional lymph node metastasis |
| pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimensio |
| pN2: Metastasis in a single ipsilateral lymph node, >3cm but <6cm, or in multiple ips |
| pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than |
| pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest |
| pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in gr |
| pN3: Metastasis in a lymph node more than 6 cm in greatest dimension |
|
|
| 70 |
PN_NASOPHARYNX_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Regional Lymph Nodes (pN): Nasopharynx. |
| May contain organization-specific values: Yes |
| Category Entries: |
| pNX: Cannot be assessed |
| pN0: No regional lymph node metastasis |
| pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, abov |
| pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above |
| pN3: Metastasis in a lymph node greater than 6 cm and / or to supraclavicular fossa## |
| pN3a: Greater than 6 cm in dimension |
| pN3b: Extension to the supraclavicular fossa## |
|
|
| 71 |
PN_HYPOPHARYNX_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Regional Lymph Nodes (pN): Hypopharynx. |
| May contain organization-specific values: Yes |
| Category Entries: |
| pNX: Cannot be assessed |
| pN0: No regional lymph node metastasis |
| pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimensio |
| pN2: Metastasis in a single ipsilateral lymph node, >3cm but <6cm, or in multiple ips |
| pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than |
| pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest |
| pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in gr |
| pN3: Metastasis in a lymph node more than 6 cm in greatest dimension |
|
|
| 72 |
REG_LYM_MUCOS_MEL_C_NAME |
VARCHAR |
No |
|
|
|
| CAP synoptic form item: Regional Lymph Nodes (pN) for Mucosal Malignant Melanoma. |
| May contain organization-specific values: Yes |
| Category Entries: |
| pNX: Cannot be assessed |
| pN0: No regional lymph node metastasis |
| pN1: Regional lymph node metastasis |
| pN1: Metastasis in perirectal lymph nodes |
| pN1: Metastasis in 1 to 3 regional lymph nodes |
| pN1a: Metastasis in 1 regional lymph node |
| pN1b: Metastasis in 2 to 3 regional lymph nodes |
| pN1c: Tumor deposit(s) in the subserosa, or non-peritonealized pericolic or perirecta |
| pN1 (IIIC1): Regional lymph node metastasis to pelvic lymph nodes |
| pN1: Regional lymph node metastasis involving 1 to 2 nodes |
| pN1 (IIIC): Regional lymph node metastasis |
| pN1: Metastases to nodes along the cystic duct, common bile duct, hepatic artery |
| pN1: Metastasis in single ipsilateral lymph node, 3 cm or less in greatest dimension |
| pN1: Metastasis in ipsilateral peribronchial and / or ipsilateral hilar lymph nodes, |
| pN1: Metastases in the ipsilateral bronchopulmonary or hilar lymph nodes |
| pN1a: Clinically occult (microscopic) metastasis |
| pN1b: Clinically apparent (macroscopic) metastasis |
| pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension |
| pN1: Metastasis in a single regional lymph node, 2 cm or less in greatest dimension |
| pN1: Metastasis in 1 to 2 perigastric lymph nodes |
| pN1: Metastasis with a lymph node mass less than 2 cm in greatest dimension, |
| pN1a: Nodal metastases to Level VI lymph nodes |
| pN1b: Metastases to unilateral, bilateral or contralateral cervical |
| pN1: Single regional lymph node metastasis in the true pelvis |
| pN1 (IVB): Pelvic or inguinal lymph node metastasis |
| pN1: Metastasis in regional lymph node or nodes |
| pN1: Regional lymph node involvement (preauricular, cervical, submandibular) |
| pN2: Metastasis in unilateral internal iliac and / or inguinal lymph node(s) |
| pN2: Metastasis in 4 or more regional lymph nodes |
| pN2: Metastasis to periaortic/pericaval/super. mesentery artery/celiac artery lym nd |
| pN2a: Metastasis in 4 to 6 regional lymph nodes |
| pN2b: Metastasis in 7 or more regional lymph nodes |
| pN2 (IIIC2): Regional lymph node metastasis to para-aortic lymph nodes, with or witho |
| pN2: 3 to 6 nodes involved |
| pN2: Metastases to periaortic,pericaval,super. mesenteric artery, celiac artery lym n |
| pN2: Metastasis in a single ipsilateral lymph node, more than 3 cm |
| pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than |
| pN2b: Metastasis in a single ipsilateral lymph nodes, none >6cm in greatest dimension |
| pN2b: Metastasis in multiple ipsilateral lymph nodes, none >6cm in greatest dimension |
| pN2c: Metastasis in bilateral/contralateral lymph nodes, none >6cm in greatest dimen. |
| pN2: Metastasis in ipsilateral mediastinal and / or subcarinal lymph node(s) |
| pN2: Metastases in the subcarinal or the ipsilateral mediastinal lymph nodes |
| pN2a: Clinically occult (microscopic) metastasis |
| pN2b: Clinically apparent (macroscopic) metastasis |
| pN2c: Satellite or in-transit metastasis without nodal metastasis |
| pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension |
| pN2: Metastasis in a single regional lymph node, more than 2 cm but not more than |
| pN2: Metastasis in 3 to 6 perigastric lymph nodes |
| pN2: Metastasis with a lymph node mass greater than 2 cm but not more than 5 cm |
| pN2: Multiple regional lymph node metastasis in the true pelvis |
| pN2: Distant lymph node involvement |
| pN3: Metastasis in perirectal and inguinal lymph nodes and / or bilateral internal il |
| pN3: 7 or more nodes involved |
| pN3: Metastasis in a lymph node more than 6 cm in greatest dimension |
| pN3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or |
| pN3: Metastases in the contralateral mediastinal, contralateral internal mammary, |
| pN3: Metastasis in 4 or more regional lymph nodes, or matted metastatic nodes, or |
| pN3: Metastasis in a lymph node greater than 6 cm and / or to supraclavicular fossa |
| pN3a: Greater than 6 cm in dimension |
| pN3b: Extension to the supraclavicular fossa |
| pN3: Metastasis in a regional lymph node more than 5 cm in greatest dimension |
| pN3: Metastasis in 7 or more perigastric lymph nodes |
| pN3a: Metastasis in 7 to 15 perigastric lymph nodes |
| pN3b: Metastasis in 16 or more perigastric lymph nodes |
| pN3: Metastasis with a lymph node mass greater than 5 cm in greatest dimension |
| pN3: Lymph node metastasis to the common iliac lymph nodes |
| pN1: One or two regional lymph nodes with the following features |
| pN2 (FIGO IIIB): Regional lymph node metastasis with the following features |
| pN3 (FIGO IVA): Fixed or ulcerated regional lymph node metastasis |
|
|
